Sanofi Caps Out-Of-Pocket Insulin Cost at $35 for Uninsured U.S. Patients More Reuters FILE PHOTO: A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France ...
Older, Recombinant Insulin May Be Effective Option for Uninsured Patients with DiabetesGeorge, Sandhya
In an announcement last year, as the US political discussion about insulin prices reached a new peak,Sanofisuggested it would reduce prices for its Lantus-brand insulin for uninsured people in the US by two-thirds, from $99 per month to $35. Together, the three drugmakers are seen as cont...
Government intervention is increasingly popular across the U.S. Eight states have imposed limits on insulin out-of-pocket costs or co-pays, but some of those laws don’t apply to uninsured patients or to Medicare, Medicaid, insurance based in a different state, or some employer-provided insura...
The issue is specific to the United States, given the nation's lack of controls on drug prices and complex insurance system that can leave people under- or uninsured, according to the watchdog group. Other nations pay far less for the life-saving medication, with a congressional report findin...
CVS Caremark said in a statement that it has “led the way in driving down the cost of insulin for all patients: insured, uninsured and underinsured,” adding that its members pay an average of less than $25, well below list prices. When brand-name drugmakers raised ...
in appropriately selected patients, this may include human insulin. Uninsured patients should have access to high-quality, low-cost insulin; for insured people, cost-sharing should be based on the lowest price available. Health plans should ensure that patients with diabetes can access insulin withou...
insured patients with skimpier plans and for Medicare enrollees facing rising out-of-pocket costs for their insulin. Some could save hundreds of dollars annually, and all insured patients would get the benefit of predictable monthly costs for insulin. The bill would not help the uninsured. ...
Sanofi established a $35 monthly cap on out-of-pocket costs for Lantus, its most widely prescribed insulin in the US, for all patients with commercial insurance starting January 1. It already limits the cost to $35 for all uninsured patients. ...
Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions.